Akebia Therapeutics, Inc. (AKBA)

$ 0.42
   
  • Change Today:
    $0.01
  • 52 Week High: $1.70
  • 52 Week Low: $0.40
  • Currency: US Dollars
  • Shares Issued: 117.12m
  • Volume: 2,066
  • Market Cap: $49.46m
  • RiskGrade: 517
  • Beta: 0.01

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 169.81 (24.75) (13.60)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 114.49 (78.58) (31.40)¢ n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

AKBA Market Data

Currency US Dollars
Share Price $ 0.42
Change Today $ 0.01
% Change 3.28 %
52 Week High $1.70
52 Week Low $0.40
Volume 2,066
Shares Issued 117.12m
Market Cap $49.46m
Beta 0.01
RiskGrade 517

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 1
Sell 0
Strong Sell 0
Total 5
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 19-Nov-2026

Time Volume / Share Price
16:00 225,511 @ $0.42
15:59 100 @ $0.42
15:59 243 @ $0.42
15:59 400 @ $0.42
15:59 100 @ $0.42

Top of Page